Reports: ZORA Program (Slovenia) - Revision history

Larysse at 16:48, 4 December 2025

2025-12-04T16:48:25Z

← Older revision		Revision as of 16:48, 4 December 2025
Line 1:		Line 1:
	<span style="display:none">forpolicymakers</span>		<span style="display:none">forpolicymakers</span>
			<span style="display:none">sloveniacountry</span>
	Go back to [[Slovenia]] page		Go back to [[Slovenia]] page

Lucas: Update categories.

2025-12-03T17:00:17Z

Update categories.

← Older revision		Revision as of 17:00, 3 December 2025
Line 30:		Line 30:
	<span style="display:none">dataLevel::national level</span>		<span style="display:none">dataLevel::national level</span>
	<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span>		<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span>
			<span style="display:none">isReport</span>

Lucas: Update categories.

2025-12-02T13:50:38Z

Update categories.

← Older revision		Revision as of 13:50, 2 December 2025
Line 1:		Line 1:
	{{forpolicymakers}}		<span style="display:none">forpolicymakers</span>
	Go back to [[Slovenia]] page		Go back to [[Slovenia]] page

Line 14:		Line 14:
	'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].		'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].

	{{Vulva}}		<span style="display:none">Vulva</span>
	{{Vagina}}		<span style="display:none">Vagina</span>
	{{Cervix}}		<span style="display:none">Cervix</span>
	{{Uterus}}		<span style="display:none">Uterus</span>
	{{Ovary}}		<span style="display:none">Ovary</span>
	{{Fallopian tubes}}		<span style="display:none">Fallopian tubes</span>
	{{Endometrium}}		<span style="display:none">Endometrium</span>
			<span style="display:none">dataOwner::Ljubljana Oncology Institute</span>
			<span style="display:none">dataOwner::ZORA Program</span>
			<span style="display:none">availableVariable::screening</span>
			<span style="display:none">availableVariable::cancer incidence\|incidence</span>
			<span style="display:none">availableVariable::number of deaths\|Mortality</span>
			<span style="display:none">availableVariable::causes of death</span>
			<span style="display:none">availableVariable::year</span>
			<span style="display:none">dataLevel::national level</span>
			<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span>

Lara at 18:59, 12 September 2024

2024-09-12T18:59:03Z

← Older revision		Revision as of 18:59, 12 September 2024
Line 13:		Line 13:

	'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].		'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].

			{{Vulva}}
			{{Vagina}}
			{{Cervix}}
			{{Uterus}}
			{{Ovary}}
			{{Fallopian tubes}}
			{{Endometrium}}

Francine at 12:20, 17 June 2024

2024-06-17T12:20:33Z

← Older revision		Revision as of 12:20, 17 June 2024
Line 6:		Line 6:
	'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].		'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].

	'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].		'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines ([[availableVariable::screening]]); The number of new patients in a given year; (RMV [[availableVariable::cancer incidence\|incidence]] rate); [[availableVariable::number of deaths\|Mortality]] due to RMV; [[availableVariable::causes of death]]; The ratio between the number of newly detected precancerous and cancerous changes per [[availableVariable::year]]. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].

	'''Data level:''' [[dataLevel::national level]].		'''Data level:''' [[dataLevel::national level]].

Francine at 17:08, 24 May 2024

2024-05-24T17:08:14Z

← Older revision		Revision as of 17:08, 24 May 2024
Line 2:		Line 2:
	Go back to [[Slovenia]] page		Go back to [[Slovenia]] page

	'''~~Sponsor, manager or home institution~~:''' ~~Ljubljana Oncology Institute; ZORA Program~~.		'''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.

	'''~~Primary purpose~~:''' ~~To actively screen and reduce morbidity and mortality from cervical cancer~~ in ~~Slovenia, aiming for at least 70% coverage~~ of ~~women aged 20~~-~~64 through regular cervical smear examinations every three years~~.		'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].

			'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].

	'''~~Type of information~~:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year.		'''Data level:''' [[dataLevel::national level]].

	'''~~Data level~~:''' ~~National level~~.		'''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. [https://zora.onko-i.si/program-zora/namen-in-cilji Click here to learn more].

	'''Access to information:''' ~~Access Information~~ [https://zora.onko-i.si/publikacije/letna-porocila].		'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access].

Francine at 15:58, 5 December 2023

2023-12-05T15:58:26Z

← Older revision		Revision as of 15:58, 5 December 2023
Line 1:		Line 1:
	{{~~#subobject:ZORA Program~~		{{forpolicymakers}}
	~~\|dct:title=ZORA Program~~		Go back to [[Slovenia]] page
	~~\|datatype=policymaking~~
	}}

	'''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program.		'''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program.

Francine: Created page with "{{#subobject:ZORA Program |dct:title=ZORA Program |datatype=policymaking }} '''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program. '''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years. '''Type of information:''' The percentage of women in the target group who are..."

2023-11-13T19:15:33Z

Created page with "{{#subobject:ZORA Program |dct:title=ZORA Program |datatype=policymaking }} '''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program. '''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years. '''Type of information:''' The percentage of women in the target group who are..."

New page

{{#subobject:ZORA Program
|dct:title=ZORA Program
|datatype=policymaking
}}

'''Sponsor, manager or home institution:''' Ljubljana Oncology Institute; ZORA Program.

'''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.

'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year.

'''Data level:''' National level.

'''Access to information:''' Access Information [https://zora.onko-i.si/publikacije/letna-porocila].